Enallylpropymal
Enallylpropymal is a barbiturate derivative that was developed in the mid-20th century. It is known for its sedative, hypnotic, and anticonvulsant properties. Enallylpropymal is chemically related to other barbiturates and shares many of their pharmacological effects.
Chemical Structure and Properties[edit | edit source]
Enallylpropymal, also known by its chemical name 5-(2-propenyl)-5-(1-propynyl)-1,3-diazinane-2,4,6-trione, is a member of the barbiturate class of drugs. The structure of enallylpropymal includes a barbituric acid core with specific substitutions that confer its unique properties.
Pharmacology[edit | edit source]
Enallylpropymal acts on the central nervous system (CNS) by enhancing the activity of the gamma-aminobutyric acid (GABA) neurotransmitter. This action results in increased inhibitory effects in the CNS, leading to sedation and hypnosis. The drug also has anticonvulsant properties, making it useful in the treatment of certain types of seizures.
Medical Uses[edit | edit source]
Enallylpropymal has been used primarily as a sedative and hypnotic agent. It has also been employed in the management of epilepsy and other seizure disorders due to its anticonvulsant effects. However, the use of enallylpropymal has declined with the development of newer medications with improved safety profiles.
Side Effects[edit | edit source]
Like other barbiturates, enallylpropymal can cause a range of side effects. Common side effects include drowsiness, dizziness, and headache. More severe side effects can include respiratory depression, hypotension, and dependence with prolonged use.
History[edit | edit source]
Enallylpropymal was first synthesized in the mid-20th century as part of efforts to develop new barbiturate derivatives with improved therapeutic profiles. It was one of many barbiturates that were investigated for their potential medical uses.
Regulation and Legal Status[edit | edit source]
Due to its potential for abuse and dependence, enallylpropymal is regulated under various national and international drug control laws. In many countries, it is classified as a controlled substance and its use is restricted to specific medical indications.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD